U.S. market Closed. Opens in 3 hours 31 minutes

DNA | Ginkgo Bioworks Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312022-11-012021-12-312020-12-312019-12-312001-12-31
Revenue251.46M477.71M379.42M313.84M76.66M54.18M98.28M
Cost of Revenue108.81M204.22M13.20M129.69M15.61MN/AN/A
Gross Profit142.64M273.49M366.22M184.15M61.05M54.18M98.28M
Operating Expenses814.87M2.48B2.35B2.01B198.07M125.78M177.87M
Selling, General & Admin289.06M1.43B1.31B862.95M38.31M29.48M77.39M
Research & Development525.81M1.05B871.49M1.15B159.77M96.30M100.48M
Other Operating Expenses9.14M7.63M174.00M-1.73M16.12M1.57MN/A
Operating Income-672.23M-2.21B-1.97B-1.83B-137.03M-71.60M-234.51M
Other Expenses / Income-220.71M87.55M41.97M-9.65M12.19M-48.24MN/A
Before Tax Income-892.94M-2.12B-1.93B-1.84B-124.83M-119.83MN/A
Income Tax Expenses-71.00K-15.03M-257.00K-1.48M1.89M22.00KN/A
Net Income-892.87M-2.10B-1.93B-1.83B-126.61M-119.33MN/A
Interest Expenses93.00K106.00K7.10M2.37M2.38M2.42MN/A
Basic Shares Outstanding48.61M41.98M1.62B34.00M1.49B1.49BN/A
Diluted Shares Outstanding48.61M42.00M1.62B34.01M1.49B1.49BN/A
EBITDA-600.68M-2.18B-1.92B-1.88B-107.52M-81.05M-219.71M
EBITDA Margin-238.88%-456.43%-506.44%-598.26%-140.25%-149.58%-223.55%
EBIT-892.85M-2.12B-1.92B-1.83B-122.33M-116.88MN/A
EBIT Margin-355.07%-443.76%-506.44%-582.84%-159.59%-215.72%0.00%
Financial Year End2023-12-312022-12-312022-11-012021-12-312020-12-312019-12-312001-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙